文献速递淋巴瘤

促炎微环境促进高巨核细胞和TPO水平小鼠的淋巴瘤进展

Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels.
PubMed 文献 · Blood Adv · 2023-01-01

研究将Eμ-myc淋巴瘤细胞移植至血小板和巨核细胞计数正常、低、高的野生型、Mpl-/-和TpoTg小鼠,发现TpoTg小鼠淋巴瘤进展增强而Mpl-/-小鼠减弱;血小板在体外支持肿瘤细胞存活,但抑制血小板功能或抗凝未改善结局;TpoTg小鼠骨髓液白细胞介素1升高,血中淋巴瘤细胞炎症基因集上调。

要点

  • TpoTg小鼠较野生型小鼠淋巴瘤进展增强,表现为白细胞计数、脾和淋巴结重量增加及肝脏浸润增强。
  • Mpl-/-荷瘤小鼠较野生型小鼠白细胞计数、淋巴结重量降低,肝脏浸润减少。
  • 抑制血小板功能或抗凝未改善Eμ-myc移植野生型小鼠的疾病结局。

核心结论

  • 作者提出TpoTg小鼠的促炎微环境促进淋巴瘤进展。

研究设计与样本

  • 将Eμ-myc淋巴瘤细胞移植到野生型对照、Mpl-/-或TpoTg受体小鼠,三者分别表现为正常、低和高血小板及巨核细胞计数。
  • 使用Mpl缺陷的血小板减少免疫缺陷小鼠模型,以人非霍奇金淋巴瘤GRANTA细胞系验证结果。

主要发现

  • 与野生型小鼠相比,TpoTg移植小鼠淋巴瘤进展增强,白细胞计数增加,脾和淋巴结重量增加,肝脏浸润增强。
  • 与野生型小鼠相比,Mpl-/-荷瘤小鼠白细胞计数降低,淋巴结重量降低,肝脏浸润减少。
  • 体外实验中血小板及血小板释放分子支持Eμ-myc肿瘤细胞存活。
  • 在Eμ-myc移植野生型小鼠中,药物抑制血小板功能或抗凝未改善疾病结局。
  • 短暂血小板清除或持续性Bcl-xL依赖性血小板减少未改变淋巴瘤进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Platelets have been shown to enhance the survival of lymphoma cell lines. However, it remains unclear whether they play a role in lymphoma. Here, we investigated the potential role of platelets and/or megakaryocytes in the progression of Eμ-myc lymphoma. Eμ-myc tumor cells were transplanted into recipient wild-type (WT) control, Mpl-/-, or TpoTg mice, which exhibited normal, low, and high platelet and megakaryocyte counts, respectively. TpoTg mice that underwent transplantation exhibited enhanced lymphoma progression with increased white blood cell (WBC) counts, spleen and lymph node weights, and enhanced liver infiltration when compared with WT mice. Conversely, tumor-bearing Mpl-/- mice had reduced WBC counts, lymph node weights, and less liver infiltration than WT mice. Using an Mpl-deficient thrombocytopenic immunocompromised mouse model, our results were confirmed using the human non-Hodgkin lymphoma GRANTA cell line. Although we found that platelets and platelet-released molecules supported Eμ-myc tumor cell survival in vitro, pharmacological inhibition of platelet function or anticoagulation in WT mice transplanted with Eμ-myc did not improve disease outcome. Furthermore, transient platelet depletion or sustained Bcl-xL-dependent thrombocytopenia did not alter lymphoma progression. Cytokine analysis of the bone marrow fluid microenvironment revealed increased levels of the proinflammatory molecule interleukin 1 in TpoTg mice, whereas these levels were lower in Mpl-/- mice. Moreover, RNA sequencing of blood-resident Eμ-myc lymphoma cells from TpoTg and WT mice after tumor transplantation revealed the upregulation of hallmark gene sets associated with an inflammatory response in TpoTg mice. We propose that the proinflammatory microenvironment in TpoTg mice promotes lymphoma progression.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Au AE, Corbin J, Lebois M, et al. Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels. Blood Adv. 2023. PMID: 36075025. doi:10.1182/bloodadvances.2022007849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。